This UBQLN (ubiquilin family rather than UBQLN2 specifically) pathology in ALS and FTLD-TDP cases with a C9ORF72 expansion was confirmed by others and is highly distinct (Brettschneider et al., 2012). This evidence concerns the gene UBQLN2 and amyotrophic lateral sclerosis.